Former Senior Vice President & Chief Financial Officer · Bioventus Inc. (BVS)

Gregory Anglum

A named executive officer of Bioventus in every fiscal year CompBrief holds from FY2020 to FY2021. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$3,718,800

Salary $425,493Stock awards $1,532,621Bonus $100

FY2020: $584,700

3rd of 3 named executive officers at Bioventus by FY2021 total.

3 named officers on file for Bioventus, FY2021

Gregory Anglum’s pay file — $29

  • 2 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Bioventus’s whole pay program stands against its peers

  • Bioventus’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BVS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A).

Free

Get Gregory Anglum’s full pay file as a PDF — free

More than this page: up to 10 years of Gregory’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Gregory Anglum compensation by year

Bioventus Summary Compensation Table · all 2 fiscal years held
In US dollars, as Bioventus reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021
Salary$381,044$425,493
Bonus$2,793$100
Stock awards$0$1,532,621
Option awards$0$1,472,070
Non-equity incentive$178,471$262,025
Pension and deferred compensation$0$0
All other$22,392$26,491
Total$584,700$3,718,800

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Bioventus Inc. DEF 14A filed April 29, 2022, accession 0001193125-22-133580, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Bioventus Inc. filed document, accession 0001193125-22-133580. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

$585K
$3.7M
FY20
FY21
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU96,876$1,403,733—
RSU4,400$63,756—
RSU9,500$54,626—
Option326,900—$13.00
Option9,100—$15.23

Per the Outstanding Equity Awards at Fiscal Year-End table in Bioventus Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Bioventus’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Kenneth RealiFormer Chief Executive Officer$12,618,883
John NosenzoFormer Senior Vice President & Chief Commercial Officer$3,807,016
Gregory Anglum · this pageFormer Senior Vice President & Chief Financial Officer$3,718,800

The full Bioventus compensation record

free company brief

This page is one person within Bioventus's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Bioventus's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Gregory Anglum's compensation dossier · One-time report. No refunds.